MedTrace Logo

Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer

NCT05352737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-07-22

No results posted yet for this study

Summary

This project aims to investigate the role of MMA in breast cancer. To this end, we will measure MMA on serum samples collected at the time of breast cancer diagnosis, to investigate the role of MMA in predicting long-term recurrence risk, response to neoadjuvant chemotherapy, and its association with age and clinical frailty.

Conditions

Interventions

DIAGNOSTIC_TEST

methylmalonic acid testing

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Hans Wildiers, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2022-06-24
Completion
2022-06-24

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352737 on ClinicalTrials.gov